| 10-Q | 2019-09-30 | Filed 2019-11-20 |
| 10-Q | 2019-06-30 | Filed 2019-08-21 |
| 10-Q | 2019-03-31 | Filed 2019-05-20 |
| 10-K | 2018-12-31 | Filed 2019-04-16 |
| 10-Q | 2018-09-30 | Filed 2018-11-20 |
| 10-Q | 2018-06-30 | Filed 2018-08-20 |
| 10-Q | 2018-03-31 | Filed 2018-07-09 |
| 10-K | 2017-12-31 | Filed 2018-07-09 |
| 10-Q | 2017-09-30 | Filed 2018-07-09 |
| 10-K | 2017-06-30 | Filed 2018-07-09 |
| 10-Q | 2017-03-31 | Filed 2017-05-22 |
| 10-K | 2016-12-31 | Filed 2017-04-17 |
| 10-Q | 2016-09-30 | Filed 2016-10-21 |
| 10-Q | 2016-06-30 | Filed 2016-08-15 |
| 10-Q | 2016-03-31 | Filed 2016-05-16 |
| 10-K | 2015-12-31 | Filed 2016-04-14 |
| 10-Q | 2015-09-30 | Filed 2015-11-16 |
| 10-Q | 2015-06-30 | Filed 2015-08-14 |
| 10-Q | 2015-03-31 | Filed 2015-05-15 |
| 10-K | 2014-12-31 | Filed 2015-03-31 |
| 10-Q | 2014-09-30 | Filed 2014-11-14 |
| 10-Q | 2014-06-30 | Filed 2014-09-08 |
| 8-K | 2020-05-19 | |
| 8-K | 2020-04-14 | |
| 8-K | 2020-02-20 | |
| 8-K | 2018-12-21 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rebel Group (REBL) | 0% | 0.0 | -1,380% | 703 | 4,933 | 140 | 0 | -9,708 | -9,660 | -395 | |
| Generex Biotechnology (GNBT) | 21% | 0.0 | -49% | 52,240 | 43,297 | 1,764 | 374 | -25,717 | -18,297 | -540 | |
| Poverty Dignified (POVD) | 0.0 | -4,053% | 49 | 3,080 | 0 | 0 | -2,000 | -1,786 | -41 | ||
| Zhong Ya (WLUC) | 0.0 | 0 | 63 | 0 | 0 | -562 | -562 | -0 | |||
| Weyland Tech (WEYL) | 18% | 2.2 | -24% | 11,699 | 2,218 | 24,630 | 4,372 | -2,779 | -2,702 | -5,821 | |
| Longbau (LNGB) | 4% | -1.0 | 2% | 10,660 | 10,136 | 4,882 | 210 | 165 | 222 | -233 | |
| Scandium International Mining (SCY) | 0.1 | -171% | 957 | 303 | 0 | 0 | -1,636 | -1,634 | -219 | ||
| Aprea Therapeutics (APRE) | 8.4 | -11% | 57,336 | 9,943 | 0 | 0 | -6,249 | -6,249 | -52,334 | ||
| IntelliSense Solutions (INLL) | 0.0 | -7,286% | 2 | 273 | 0 | 0 | -178 | -164 | -2 | ||
| Metropolitan Life Insurance (MLIC) | 0% | -1.8 | 1% | 437,745,000 | 403,121,000 | 37,348,000 | 0 | 4,559,000 | 4,960,000 | -8,986,000 | |
| Zeta Acquisition I (ZETAI) | 0.2 | -649% | 4 | 324 | 0 | 0 | -29 | -18 | -4 | ||
| Ando Holdings (ANDO) | 1.1 | -74% | 73 | 160 | 0 | 0 | -54 | -54 | -61 | ||
| Po Yuen Cultural (POYE) | 0.0 | -1,973% | 1 | 68 | 0 | 0 | -20 | -20 | -0 | ||
| Advanced Biomedical Technologies (ABMT) | 0.0 | -321% | 218 | 6,589 | 0 | 0 | -701 | -701 | -11 | ||
| Kyto Technology & Life Science (KBPH) | 0% | 0.8 | -12% | 2,578 | 66 | 15 | 0 | -315 | -315 | -238 | |
| Federal Home Loan Bank of Topeka (FHLBT) | 29.6 | 0% | 57,131,130 | 54,472,808 | 0 | 0 | 132,964 | 1,095,234 | 32,380,961 | ||
| CNL Healthcare Properties II (CHPII) | 67% | -4.4 | 68,889,100% | 8,277 | 5,549 | -689 | 1,137 | -4,981 | |||
| Original Source Music (OSMU) | 0.0 | 743,400% | 35 | 0 | 0 | -7 | -7 | -0 | |||
| Graham Alternative Investment Fund I (GAIF) | -0.0 | 0% | 29,076 | 1,126 | 0 | 0 | 0 | 5 | -0 | ||
| JiaLiJia Group (RZZN) | 0.0 | -1,721% | 4 | 139 | 0 | 0 | -69 | -69 | -0 |
| Balance Sheet ($'000) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 135 | 115 | 107 | 133 | 80 | 73 | 80 | 2 | 41 | 17 | 304 | 521 | 469 | 565 | 435 | 464 | 488 | 509 | 341 | 384 | 233 |
| Accounts Receivable | 24 | 48 | 72 | 55 | 0 | 0 | 0 | 877 | 59 | 146 | 840 | 217 | 671 | 772 | 940 | 177 | 110 | 244 | |||
| Inventory | 508 | 509 | 416 | 359 | 399 | 371 | 381 | 368 | 364 | 360 | 326 | ||||||||||
| PP&E | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 2,524 | 299 | 281 | 387 | 355 | 325 | 323 | 427 | 80 | 86 | 79 |
| Assets | 163 | 167 | 182 | 191 | 83 | 120 | 89 | 72 | 49 | 25 | 11,839 | 11,326 | 11,348 | 11,371 | 11,711 | 11,642 | 11,681 | 11,798 | 10,786 | 10,768 | 10,660 |
| Accounts Payable | |||||||||||||||||||||
| Long-Term Debt | |||||||||||||||||||||
| Liabilities | 10 | 74 | 149 | 194 | 172 | 180 | 190 | 218 | 235 | 261 | 11,242 | 10,654 | 10,661 | 10,971 | 11,182 | 10,913 | 10,803 | 11,310 | 10,390 | 10,289 | 10,136 |
| Stockholders' Equity | 153 | 93 | 33 | -3 | -89 | -60 | -101 | -146 | -186 | -236 | 597 | 672 | 687 | 401 | 528 | 728 | 878 | 488 | 396 | 479 | 524 |
| Income Statement ($'000) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | 24 | 24 | 27 | 18 | 0 | 97 | -5 | 0 | 0 | 0 | 2,235 | 1,150 | 1,835 | 2,353 | 1,297 | 2,369 | 3,295 | 1,031 | 1,861 | 1,990 | |
| Cost of Revenue | 24 | 0 | 0 | 1,599 | 554 | 1,269 | 884 | 1,731 | 2,201 | 821 | |||||||||||
| Gross Profit | 73 | -6 | 0 | 636 | 596 | 566 | 413 | 637 | 1,093 | 210 | |||||||||||
| R&D | |||||||||||||||||||||
| SG&A | 18 | 82 | 82 | 54 | 87 | 46 | 26 | 46 | 39 | 50 | 408 | 590 | 524 | 169 | 366 | 409 | 704 | 329 | 455 | 322 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 56 | 14 | 3 | -6 | 8 | 9 | 29 | 0 | 20 | 11 | ||
| Net Income | 6 | -21 | -56 | -37 | -86 | 26 | -32 | -46 | -40 | -51 | 81 | 22 | 12 | -11 | 330 | 189 | -83 | 193 | 54 | ||
| Cash Flow ($'000) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | -14 | -4 | 25 | -53 | -5 | 18 | -17 | -23 | -25 | -302 | 15 | -26 | 40 | 124 | -215 | 139 | -95 | ||||
| Cash Investing | 0 | -60 | 0 | 84 | -241 | 109 | -40 | 0 | -18 | 0 | |||||||||||
| Cash Financing | 0 | 0 | 0 | 0 | 0 | 0 | 92 | 93 | -299 | 0 | 0 | 0 | 36 | -97 | -66 | ||||||